Sort
50,496 grants matching “lung cancer”
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
$635,757Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2023 · CA
Multi-Pathway DNA Repair Capacity Measurements in Lung Cancer Patients and Healthy Controls
$635,628Zachary David Nagel · Harvard School Of Public Health · U01 · FY2019 · ES
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers
$635,583Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2024 · CA
Impact of mutation burden on cancer growth and the immune landscape
$635,557Shridar Ganesan · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Lung Tissue Engineering
$635,429Laura E Niklason · Yale University · R01 · FY2010 · HL
Anaplerotic reprogramming of endothelial cells in pulmonary hypertension
$635,427Ruslan Rafikov · University Of Arizona · R01 · FY2023 · HL
A Personalized Digital Outreach Intervention for Lung Cancer Screening
$635,420David P Miller · Wake Forest University Health Sciences · R01 · FY2020 · CA
ELUCIDATING THE ONCOGENIC ROLE OF EMSY IN NON-SMALL CELL LUNG CANCER.
$635,417Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency
Clinical Laboratory Core
$635,387Jennifer W Tidey · Brown University · P20 · FY2022 · GM
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA
$635,296Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Optimizing Effectiveness of Smoking Cessation Intervention During LDCT screening for Lung Cancer
$635,290Paul Michael Cinciripini · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$635,258Edward B Garon · University Of California Los Angeles · R01 · FY2018 · CA
Modified saRNA Encoded BiTEs for Lung Cancer
$635,248Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2025 · CA
Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking
$635,217Jonathan B Bricker · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$635,207Edward B Garon · University Of California Los Angeles · R01 · FY2021 · CA
Evaluating Cigarette Relighting Behavior: Prevalence, Correlates, Toxicant Exposure, and Implications for Cessation
$635,190Michael B. Steinberg · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$635,187Edward B Garon · University Of California Los Angeles · R01 · FY2020 · CA
T-cell subsets as CVD risk factors in CHS and MESA
$635,172Bruce M Psaty · University Of Washington · R01 · FY2016 · HL
Molecular Diagnostics Core Laboratory
$635,058Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing
$634,988David Sidransky · Johns Hopkins University · R01 · FY2020 · CA
RCT of An Internet Cessation Program Plus Online Social Network for HIV + Smokers
$634,880Jonathan Shuter · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
Engineering Dual-Targeted Nanoplatforms to Effectively Treat NSCLC.
$634,874Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2024 · EB
Validation of Immunometabolic NLRX1 Therapeutics for IBD
$634,825Andrew Leber · Biotherapeutics, Inc. · R44 · FY2020 · DK
Vanberbilt Biomarker Developmental Laboratory
$634,744Daniel C Liebler · Vanderbilt University · U01 · FY2012 · CA
A novel molecularly targeted theranostic approach via the alphavbeta6 integrin for the detection and treatment of metastatic cancers
$634,742Julie L Sutcliffe · University Of California At Davis · R01 · FY2024 · CA